Eculizumab

Records for this ingredient, by country (identity only).

ATC L04AJ01 · 12 markets · 26 records

Eculizumab 12 markets · 26 records Forms
Filters

US 3 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 300 mg/30 mLinjectionBKEMVEPYSQLI、SOLIRIS also in GB·AU·FR
    +2Other 2 marketsCNJP

GB 3 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 300 mg/30 mLinjectionBekemv 300mg/30ml concentrate for solution for infusion vialsEpysqli 300mg/30ml concentrate for solution for infusion vials、Soliris 300mg/30ml concentrate for solution for infusion vials also in US·AU·FR
    +2Other 2 marketsCNJP

AU 3 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 300 mg/30 mLinjectionSOLIRIS also in US·GB·FR
    +2Other 2 marketsCNJP
  • 300 mg per mL / per unit basis not statedinjectionSOLIRIS eculizumab 300 mg/30 mL concentrated solution for intravenous infusion vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

ES 3 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

  • 300 mg per mL / per unit basis not statedinjectionBEKEMVEPYSQLI、SOLIRIS

EU 3 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名BEKEMV ×1EPYSQLI ×2SOLIRIS ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 3 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 300 mg/30 mLinjectionBEKEMV 300 mg, solution à diluer pour perfusionEPYSQLI 300 mg, solution à diluer pour perfusion、SOLIRIS 300 mg, solution à diluer pour perfusion also in US·GB·AU
    +2Other 2 marketsCNJP

CA 2 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 10 mg per mL / per unit basis not statedliquidEPYSQLISOLIRIS

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 300 mg/vial per mL / per unit basis not statedinjectionSoliris Concentrate for Solution for Infusion 300mg/vial

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Soliris 300 mg concentrate for solution for infusion ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 300 mg/30 mLinjectionソリリス点滴静注300mg also in US·GB·AU
    +2Other 2 marketsFRCN

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.